Bhopal: City is facing an emerging public health concern as stocks of life-saving anti-rabies vaccines at JP Hospital are ...

The OPUS-2 trial will also evaluate the safety, tolerability, and immune response of VAX-31 in adults aged 50 and older. But ...

However, Moderna's deep pipeline and innovative technology could eventually allow it to improve and deliver excellent returns ...

Vaxcyte Inc (NASDAQ:PCVX) is among the best 52-week high US stocks to buy. Vaxcyte Inc (NASDAQ:PCVX) has completed enrollment ...

As wealthy nations scramble to secure stocks of oil, the result is higher prices for all and shortages in vulnerable ...

DaVita is set to announce its first-quarter results in May, with analysts forecasting a double-digit increase in the ...

Australia’s sharemarket has recorded its worst day in three weeks, as a sell-off in the big four banks and a major healthcare ...

The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

PM UTC It will lose patent exclusivity within the next two years, but Merck has earned approval for a new, subcutaneous ...